Sotera Health Company (SHC) Earnings History
Profitable8 years of earnings data (2018–2025) · Positive TTM net income
Loading earnings history...
Sotera Health Company (SHC) Earnings Overview
As of June 22, 2026, Sotera Health Company (SHC) reported trailing twelve-month net income of $118M, reflecting +68.8% year-over-year growth. The company earned $0.41 per diluted share over the past four quarters, with a net profit margin of 6.7%.
Looking at the long-term picture, SHC's historical earnings data spans multiple years. The company achieved its highest annual net income of $117M in fiscal 2021.
Sotera Health Company maintains positive profitability with a gross margin of 55.5%, operating margin of 33.8%, and net margin of 6.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including STRL ($347M net income, 11.7% margin), ICLR ($489M net income, 2.8% margin), CRL (-$185M net income, -3.6% margin), SHC has room to improve margins relative to the peer group. Compare SHC vs STRL →
SHC Earnings vs Peers
Earnings metrics vs comparable public companies
SHC Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $78M | +75.6% | $393M | $0.27 | 6.7% | 33.8% |
| 2024 | $44M | -13.6% | $298M | $0.16 | 4.0% | 27.0% |
| 2023 | $51M | +122.0% | $277M | $0.18 | 4.9% | 26.4% |
| 2022 | -$234M | -299.8% | $248M | $-0.83 | -23.3% | 24.7% |
| 2021 | $117M | +402.7% | $257M | $0.41 | 12.5% | 27.6% |
| 2020 | -$39M | -85.2% | $206M | $-0.14 | -4.7% | 25.2% |
| 2019 | -$21M | -255.2% | $184M | $-0.07 | -2.7% | 23.6% |
| 2018 | -$6M | - | $81M | $-0.02 | -0.8% | 10.8% |
Download Data
Export SHC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SHC — Frequently Asked Questions
Quick answers to the most common questions about buying SHC stock.
What is SHC earnings per share (EPS)?
SHC trailing twelve-month (TTM) diluted EPS is $0.41, reflecting +68.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Sotera Health Company's net income?
Sotera Health Company (SHC) trailing twelve-month net income is $118M as of 2025. Earnings grew +68.8% year-over-year. Sotera Health Company has been profitable for 3 consecutive years.
Is SHC profitable?
Yes, SHC is profitable with a TTM net income of $118M and a net profit margin of +6.7%. Sotera Health Company has generated profits for 3 consecutive years.
What is SHC's earnings growth rate?
SHC compound annual EPS growth rates (CAGR): 1-Year: +68.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are SHC's profit margins?
Sotera Health Company net profit margin is +6.7%, operating margin is +33.8%, and gross margin is +55.5%. Margins are within a typical range for the sector. Return on Equity is +15.4%.
Is SHC growing earnings?
Yes, SHC earnings are accelerating — EPS growth of +68.8% exceeds the 5-year CAGR of N/A. TTM net income reached $118M. Earnings momentum is strengthening.
What was SHC's best earnings year?
Sotera Health Company's highest annual net income on record is $117M, achieved in fiscal year 2021. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were SHC's earnings last quarter?
SHC's most recent reported quarter was Q1 2026. Net income was $27M with diluted EPS of $0.09. For a full breakdown of all quarters, see the quarterly earnings table on this page.